Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 143489, 12 pages
http://dx.doi.org/10.1155/2012/143489
Research Article

Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice

1Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan
2Iskra Industry Co., Ltd., 1-14-2 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan
3Department of Oriental Medicine Resources, Sunchon National University, 315 Maegok-dong, Jeonnam 540-742, Republic of Korea
4Organization for Promotion of Regional Collaboration, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan

Received 16 November 2011; Revised 22 June 2012; Accepted 22 June 2012

Academic Editor: Vassya Bankova

Copyright © 2012 Chan Hum Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Targher, L. Bertolini, R. Padovani et al., “Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients,” Diabetes Care, vol. 30, no. 5, pp. 1212–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7122, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Li and A. M. Shah, “ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, supplement 3, pp. S221–S226, 2003. View at Google Scholar · View at Scopus
  4. P. Newsholme, E. P. Haber, S. M. Hirabara et al., “Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity,” Journal of Physiology, vol. 583, no. 1, pp. 9–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. F. Ceylan-Isik, R. M. Fliethman, L. E. Wold, and J. Ren, “Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus,” Current Diabetes Reviews, vol. 4, no. 4, pp. 320–328, 2008. View at Google Scholar · View at Scopus
  6. L. C. Winslow and D. J. Kroll, “Herbs as medicines,” Archives of Internal Medicine, vol. 158, no. 20, pp. 2192–2199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. L. N. Xu, Z. Z. Yin, and Y. R. Ou, “The effect of compositus Guan-Xin NO 2 on myocardial ischaemia and hypoxia in experimental animals,” Yao Xue Xue Bao, vol. 14, no. 8, pp. 461–466, 1979. View at Google Scholar · View at Scopus
  8. M. Takahashi, K. Sugaya, and K. Kubota, “Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion,” Japanese Journal of Pharmacology, vol. 60, no. 3, pp. 307–310, 1992. View at Google Scholar · View at Scopus
  9. M. Gao, K. Ikeda, T. Noguchi, K. Mori, and Y. Yamori, “Studies on preventive effect of ‘Kangenkaryu’, Chinese herbal medicine, on stroke in SHR-SP,” Journal of Traditional Medicines, vol. 18, no. 6, pp. 245–250, 2001. View at Google Scholar
  10. T. Makino, H. Wakushima, T. Okamoto, Y. Okukubo, K. Saito, and Y. Kano, “Effects of Kangen-karyu on coagulation system and platelet aggregation in mice,” Biological & Pharmaceutical Bulletin, vol. 25, no. 4, pp. 523–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Cho, T. Okamoto, and T. Yokozawa, “Therapeutic efficacy of Kangen-karyu against H2O2-induced premature senescence,” Journal of Pharmacy and Pharmacology, vol. 60, no. 11, pp. 1537–1544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Y. Kim, T. Okamoto, and T. Yokozawa, “Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 263–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Yamabe, H. Y. Kim, K. S. Kang, Q. Zhao, K. Matsumoto, and T. Yokozawa, “Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice,” Journal of Ethnopharmacology, vol. 129, no. 3, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Noh, C. H. Park, H. Y. Kim et al., “Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes,” Journal of Pharmacy and Pharmacology, vol. 63, no. 1, pp. 111–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Okamoto, C. H. Park, J. S. Noh et al., “Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes,” Journal of Pharmacy and Pharmacology, vol. 63, no. 7, pp. 952–959, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. F. Ali, C. P. LeBel, and S. C. Bondy, “Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity,” Neurotoxicology, vol. 13, no. 3, pp. 637–648, 1992. View at Google Scholar · View at Scopus
  17. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  18. S. Komatsu, “Extraction of nuclear proteins.,” Methods in Molecular Biology, vol. 355, pp. 73–77, 2007. View at Google Scholar · View at Scopus
  19. R. Kakkar, S. V. Mantha, J. Radhi, K. Prasad, and J. Kalra, “Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes,” Clinical Science, vol. 94, no. 6, pp. 623–632, 1998. View at Google Scholar · View at Scopus
  20. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Rossetti, A. Giaccari, N. Barzilai, K. Howard, G. Sebel, and M. Hu, “Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes,” Journal of Clinical Investigation, vol. 92, no. 3, pp. 1126–1134, 1993. View at Google Scholar · View at Scopus
  22. J. Allison, H. Thomas, D. Beck et al., “Transgenic overexpression of human Bcl-2 in islet β cells inhibits apoptosis but does not prevent autoimmune destruction,” International Immunology, vol. 12, no. 1, pp. 9–17, 2000. View at Google Scholar · View at Scopus
  23. U. J. Jung, N. I. Baek, H. G. Chung et al., “Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice,” Clinical Nutrition, vol. 27, no. 1, pp. 158–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. C. Davis, L. W. Castellani, M. Hosseini et al., “Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice,” Diabetes, vol. 59, no. 7, pp. 1616–1625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. W. Lee, S. W. Chun, S. H. Kim et al., “Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1,” Toxicology and Applied Pharmacology, vol. 252, no. 1, pp. 47–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. M. Babior, J. D. Lambeth, and W. Nauseef, “The neutrophil NADPH oxidase,” Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 342–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Gao and G. E. Mann, “Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling,” Cardiovascular Research, vol. 82, no. 1, pp. 9–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. I. Tong, Y. Katoh, H. Kusunoki, K. Itoh, T. Tanaka, and M. Yamamoto, “Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2887–2900, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. Anwar, F. Y. L. Li, D. S. Leake, T. Ishii, G. E. Mann, and R. C. M. Siow, “Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2,” Free Radical Biology & Medicine, vol. 39, no. 2, pp. 227–236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. He, R. C. M. Siow, D. Sugden, L. Gao, X. Cheng, and G. E. Mann, “Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 4, pp. 277–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. T. Churchman, A. A. Anwar, F. Y. L. Li et al., “Transforming growth factor-β1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 2282–2292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Siebenlist, G. Franzoso, and K. Brown, “Structure, regulation and function of NF-κB,” Annual Review of Cell Biology, vol. 10, pp. 405–455, 1994. View at Google Scholar · View at Scopus
  33. V. García-Mediavilla, I. Crespo, P. S. Collado et al., “The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells,” European Journal of Pharmacology, vol. 557, no. 2-3, pp. 221–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. C. de Luca and J. M. Olefsky, “Inflammation and insulin resistance,” FEBS Letters, vol. 582, no. 1, pp. 97–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. S. Hsieh, J. S. Jin, C. F. Chiang, P. C. Chan, C. H. Chen, and K. C. Shih, “COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver,” Obesity, vol. 17, no. 6, pp. 1150–1157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Google Scholar · View at Scopus
  37. A. Sachse and G. Wolf, “Angiotensin II-induced reactive oxygen species and the kidney,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2439–2446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Civera, A. Urios, M. L. Garcia-Torres et al., “Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 187–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. L. Brezniceanu, F. Liu, C. C. Wei et al., “Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells,” Diabetes, vol. 57, no. 2, pp. 451–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Crompton, “Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis,” Current Opinion in Cell Biology, vol. 12, no. 4, pp. 414–419, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Garcia-Ruiz and J. C. Fernández-Checa, “Redox regulation of hepatocyte apoptosis,” Journal of Gastroenterology and Hepatology, vol. 22, supplement 1, pp. S38–S42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Behrens, M. Sibilia, and E. F. Wagner, “Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation,” Nature Genetics, vol. 21, no. 3, pp. 326–329, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Kriehuber, W. Bauer, A. S. Charbonnier et al., “Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death,” Blood, vol. 106, no. 1, pp. 175–183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Czaja, “The future of GI and liver research: editorial perspectives III. JNK/AP-1 regulation of hepatocyte death,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 284, no. 6, pp. G875–G879, 2003. View at Google Scholar · View at Scopus
  45. K. Hase, R. Kasimu, P. Basnet, S. Kadota, and T. Namba, “Preventive effect of lithospermate B from Salvia miltiorrhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide,” Planta Medica, vol. 63, no. 1, pp. 22–26, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Mueller, B. Lukas, J. Novak, T. Simoncini, A. R. Genazzani, and A. Jungbauer, “Oregano: a source for peroxisome proliferator-activated receptor γ antagonists,” Journal of Agricultural and Food Chemistry, vol. 56, no. 24, pp. 11621–11630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. H. O. Yang, W. K. Ko, J. Y. Kim, and H. S. Ro, “Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora,” Fitoterapia, vol. 75, no. 1, pp. 45–49, 2004. View at Publisher · View at Google Scholar · View at Scopus